GoodRx Holdings, Inc.

How big is GoodRx Holdings, Inc.?

As of Jun 18, GoodRx Holdings, Inc. has a market capitalization of $1,567.97 million, with net sales of $797.41 million and a net profit of $28.44 million for the latest four quarters. The balance sheet as of Dec'24 shows shareholder's funds of $724.66 million and total assets of $1,388.07 million.

As of Jun 18, GoodRx Holdings, Inc. has a market capitalization of 1,567.97 million, categorizing it as a Small Cap company.<BR><BR>As of Jun 18, the company reported net sales of 797.41 million and a net profit of 28.44 million for the latest four quarters ending in Mar'25, Dec'24, Sep'24, and Jun'24.<BR><BR>As of Dec'24, the balance sheet shows shareholder's funds of 724.66 million and total assets of 1,388.07 million.

What does GoodRx Holdings, Inc. do?

GoodRx Holdings, Inc. is a holding company that offers a prescription price comparison tool, categorized as a small-cap company with a market cap of approximately $1.57 billion. As of March 2025, it reported net sales of $203 million and a net profit of $11 million.

Overview: <BR>GoodRx Holdings, Inc. is a holding company that provides a price comparison tool for prescriptions, operating within the Computers - Software & Consulting industry and categorized as a small-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 203 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 11 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 1,567.97 Million (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 38.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.30 <BR>Return on Equity: 5.92% <BR>Price to Book: 2.40<BR><BR>Contact Details: <BR>Address: 2701 Olympic Boulevard, Suite 990, SANTA MONICA CA: 90404 <BR>Fax: 1 302 6365454

Should I buy, sell or hold GoodRx Holdings, Inc.?

Is GoodRx Holdings, Inc. technically bullish or bearish?

As of September 8, 2025, GoodRx Holdings, Inc. is in a bearish trend with weak strength indicators, as shown by the MACD and KST, and has significantly underperformed the S&P 500 with a 1-year return of -42.45%.

As of 8 September 2025, the technical trend for GoodRx Holdings, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a weak strength indicated by the weekly MACD and KST both showing bearish signals, along with daily moving averages confirming the bearish trend. The Bollinger Bands also reflect a bearish condition on the monthly timeframe. Additionally, the stock has underperformed significantly compared to the S&P 500 across multiple periods, with a 1-year return of -42.45% versus the S&P 500's 17.14%.

Is GoodRx Holdings, Inc. overvalued or undervalued?

As of November 21, 2025, GoodRx Holdings, Inc. is considered very attractive in valuation, with a P/E ratio of 38, favorable EV to EBITDA ratio of 9.64, and strong ROCE and ROE metrics, indicating it is undervalued compared to peers like PropertyGuru and ZipRecruiter.

As of 21 November 2025, the valuation grade for GoodRx Holdings, Inc. has moved from attractive to very attractive, indicating a significant improvement in its perceived value. The company appears to be undervalued, particularly when considering its P/E ratio of 38, which is notably higher than the peer average of approximately 31.76 for similar companies. Additionally, the EV to EBITDA ratio stands at 9.64, which is relatively favorable compared to the industry context.<BR><BR>In terms of peer comparisons, GoodRx's P/E ratio is substantially better than that of PropertyGuru Group Ltd., which has a P/E of -132.05, and ZipRecruiter, Inc. with a P/E of -12.45. The company's ROCE of 11.40% and ROE of 5.92% further support its attractive valuation metrics. Although specific return data is not available, the lack of negative performance relative to the S&P 500 suggests that GoodRx is maintaining a competitive stance in the market.